Acrivon Therapeutics, Inc. Common StockACRVNASDAQ
Loading
Cash & Equivalents Over TimeStable
Percentile Rank80
3Y CAGR+12.0%
5Y CAGR+92.2%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+12.0%/yr
Annual compound
5Y CAGR
+92.2%/yr
Recent deceleration
Percentile
P80
Within normal range
vs 5Y Ago
26.2x
Strong expansion
Streak
3 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $41.50M | +4.2% |
| 2024 | $39.82M | +10.6% |
| 2023 | $36.02M | +22.0% |
| 2022 | $29.52M | -70.4% |
| 2021 | $99.60M | +6192.0% |
| 2020 | $1.58M | - |